On December 19, 2024, Budd Haeberlein Samantha L., a Director at Vigil Neuroscience Inc (VIGL, Financial), purchased 12,000 shares of the company. Following this transaction, the insider now owns a total of 12,000 shares. The purchase was documented in an SEC Filing.
Vigil Neuroscience Inc is a biotechnology company focused on developing treatments for neurodegenerative diseases. The company aims to address unmet medical needs in the field of neuroscience.
The insider's recent acquisition is part of a broader trend within the company. Over the past year, there have been four insider buys and zero insider sells at Vigil Neuroscience Inc. This indicates a pattern of insider confidence in the company's prospects.
On the day of the purchase, shares of Vigil Neuroscience Inc were trading at $1.71 each, resulting in a market cap of $67.860 million. The company's valuation metrics, such as GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, provide further insights into the stock's current market position.
This insider buying activity by Budd Haeberlein Samantha L. reflects a positive sentiment towards the company's future performance.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
